<DOC>
	<DOCNO>NCT00002236</DOCNO>
	<brief_summary>The purpose study see whether good take delavirdine ( DLV ) plus indinavir ( IDV ) plus zidovudine ( ZDV ) twice day three time day .</brief_summary>
	<brief_title>A Study Find Best Dosing Schedule Delavirdine , Zidovudine , Indinavir HIV-Positive Patients</brief_title>
	<detailed_description>Patients divide 2 treatment group ; group balance respect viral load . Group A receive ZDV , DLV , IDV 3 time daily . Group B receive ZDV , DLV , IDV 2 time daily . Patients evaluate change baseline viral load CD4 cell count .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Delavirdine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are HIVpositive . Have viral load ( level HIV blood ) least 20,000 copies/ml . Have CD4 cell count least 50 cells/mm3 . Are least 14 year old ( consent parent guardian require 18 ) . Exclusion Criteria You eligible study : Have ever take antiHIV drug ZDV . Have take ZDV 1 month .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2000</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Drug Administration Schedule</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>CD4 Lymphocyte Count</keyword>
	<keyword>Indinavir</keyword>
	<keyword>Delavirdine</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
</DOC>